论文部分内容阅读
早在本世纪50年代,已有人注意到静脉输入大量新鲜血浆可使血小板减少病人的血小板数上升。Imbach观察到Wiscott-Aldrich综合征合并血小板减少并伴有低丙种球蛋白血症者以大剂量免疫球蛋白静脉输入(IVIg)后,血小板明显增高。1981年他报告大剂量静脉输入免疫球蛋白治疗13例特发性血小板减少性紫癜(idiopathic thrombocytopenic purpura,ITP),取得良好效果。近年来在欧洲和美国,IVIg疗法已用于治疗儿童和成人ITP,对慢性型或急
As early as 50s of this century, it has been noticed that intravenous infusion of large amounts of fresh plasma can increase the number of platelets in patients with thrombocytopenia. Imbach observed platelet aggregation in patients with Wiscott-Aldrich syndrome with thrombocytopenia accompanied by low-gammaglobulinemia after intravenous infusion of high-dose immunoglobulin (IVIg). In 1981 he reported a high dose of intravenous immunoglobulin treatment of 13 cases of idiopathic thrombocytopenic purpura (idiopathic thrombocytopenic purpura, ITP), and achieved good results. In recent years in Europe and the United States IVIg therapy has been used to treat children and adults with ITP, chronic type or urgency